These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15824332)

  • 1. Conventional wisdom vs reality in stroke prevention.
    Barnett HJ
    Neurology; 2005 Apr; 64(7):1122-4. PubMed ID: 15824332
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in prevention and health services delivery 2009.
    Goldstein LB; Rothwell PM
    Stroke; 2010 Feb; 41(2):e71-3. PubMed ID: 20075352
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy of neurovascular disease.
    Weinberger J; Terashita D
    Heart Dis; 1999; 1(3):163-78. PubMed ID: 11720620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
    Bertelli M; Luongo R; Barcella L; Cavalli P
    Panminerva Med; 2008 Sep; 50(3):260-1. PubMed ID: 18927532
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
    Busse O; Diener HC; Grond M
    Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient ischemic attack: risk stratification and treatment.
    Cucchiara B; Ross M
    Ann Emerg Med; 2008 Aug; 52(2):S27-39. PubMed ID: 18655916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into stroke in chronic kidney disease.
    Khella SL
    Adv Chronic Kidney Dis; 2008 Oct; 15(4):338-46. PubMed ID: 18805379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
    Lutsep HL
    Am J Med; 2009 Apr; 122(4 Suppl 2):S21-31. PubMed ID: 19332240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alternatives of stroke prevention increasing].
    Lindsberg PJ; Roine RO; Kaste M
    Duodecim; 2001; 117(9):917-9. PubMed ID: 12116915
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics.
    Cheng-Ching E; Samaniego EA; Naravetla BR; Zaidat OO; Hussain MS
    Neurology; 2012 Sep; 79(13 Suppl 1):S68-76. PubMed ID: 23008416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH; Algra A
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants and antiplatelet drugs.
    Gallus AS
    Med J Aust; 1994 Jan; 160(2):78-82. PubMed ID: 8309373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.